Steroid Withdrawal Syndrome (TSW) and Eczema Symptoms

Steroid Withdrawal Syndrome (TSW) and Eczema Symptoms

High-potency topical corticosteroids (TCS) are commonly used to manage eczema flare-ups, but their long-term use can have severe consequences.

Eczema, a chronic inflammatory skin condition, can range from mild to severe, with people typically experiencing flare-ups. Moderate topical steroids, such as clobetasone butyrate, triamcinolone acetonide, and desoximetasone, are often prescribed for eczema treatment. However, extended use of these steroids can lead to skin thinning (atrophy), stretch marks (striae), pigment changes, steroid-induced dermatoses, other local side effects, systemic effects, and withdrawal symptoms upon discontinuation.

Skin thinning, caused by corticosteroids breaking down collagen, makes the skin fragile, thin, more translucent, and prone to bruising or tearing. Prolonged steroid use can also lead to permanent lines, known as stretch marks, especially on large or sensitive areas. Pigment changes, including hypopigmentation (lightening) or hyperpigmentation (darkening), can occur where steroids are applied, potentially distressing for people with darker skin tones.

Steroid-induced dermatoses include perioral dermatitis, steroid acne, and rosacea-like eruptions, often appearing as red bumps or pustules. Other local side effects include increased hair growth (hypertrichosis), bruising, spider veins (telangiectasias), and delayed wound healing due to immune suppression.

Systemic effects, while rare but serious, can include fatigue, weakness, or weight loss due to HPA axis suppression. Prolonged exposure to absorbed corticosteroids can cause iatrogenic Cushing's syndrome, characterized by weight gain, high blood pressure, and high blood sugar.

Upon discontinuation of topical steroids, Topical Steroid Withdrawal Syndrome (TSWS) can occur. Symptoms include burning, redness, peeling skin, intense itching, and psychological symptoms such as anxiety and depression. In some cases, rebound flare-ups of eczema or dermatitis symptoms may occur, sometimes more severe than before treatment.

Tachyphylaxis, or reduced response to steroids over time, can occur with prolonged mid- to high-potency steroid use, diminishing effectiveness. Proper medical guidance with limited duration and regular monitoring can minimize risks of side effects and withdrawal. Personalized long-term management plans relying less on high-potency steroids help reduce these risks.

In rare cases, Topical Steroid Withdrawal may occur within days or weeks of stopping treatment, with symptoms that can be worse than the original skin condition. Discontinuing topical steroids is typically the first step in treating TSW, but other potential treatments may include oral steroids, tetracycline antibiotics, antihistamines, calcineurin inhibitors, and a medication called dupilumab (which treats eczema and asthma).

It is essential to consult a doctor before stopping the use of topical steroids, as sudden discontinuation can exacerbate symptoms. Topical steroids come in several forms such as creams, lotions, ointments, and gels, and their strength ranges from mild to ultra-high potency. Ultra-high potency topical steroids include clobetasol propionate, halobetasol propionate, and diflorasone diacetate 0.05%.

The most common type of eczema is atopic dermatitis, and research does not yet fully understand the exact causes of TSW. However, people who use topical steroids over a long period of time, and those who use moderate to high strength topical steroids daily, are at higher risk of developing TSW.

Symptoms of eczema can include itchy skin, dry skin, skin discoloration, inflammation, thick, hard, scaly patches of skin, rashes that may start weeping, and swollen skin. In lighter skin, eczema patches may appear red, while in darker skin, eczema patches may appear gray, purple, or dark brown.

People who are experiencing pain or discomfort that interferes with their day-to-day life or sleep schedule should speak with a doctor. Topical steroids are the most common medications for the treatment of eczema, but careful medical supervision and alternative therapies should be considered for long-term management.

1. Switchers, seeking alternative treatments for their eczema, should be aware of the risks associated with Topical Steroid Withdrawal (TSWS) when discontinuing high-potency topical corticosteroids (TCS).
2. Entity seekers with chronic eczema may discover that long-term use of moderate to high-strength TCS can lead to steroid-induced dermatoses, such as perioral dermatitis and rosacea-like eruptions.
3. Personas with eczema should be mindful of the potential side effects of HST, including skin thinning, pigment changes, and systemic effects like Cushing's syndrome.
4. Advertisements promoting medical-condition treatments, such as skin care for chronic diseases like eczema, should disclose the risks of long-term TCS use and the importance of proper medical guidance.
5. Science has shown that eczema sufferers may experience a rebound flare-up upon discontinuation of TCS, making personalized long-term management plans relying less on high-potency steroids crucial.
6. In the realm of health-and-wellness, it's fundamental for medical-condition seekers to understand the potential withdrawal symptoms, including TSW, and the benefits of alternative therapies for eczema treatment.

Read also: